X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ABBOTT INDIA - Comparison Results

WOCKHARDT    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ABBOTT INDIA WOCKHARDT/
ABBOTT INDIA
 
P/E (TTM) x -20.0 39.7 - View Chart
P/BV x 1.4 10.6 13.2% View Chart
Dividend Yield % 0.0 0.7 0.4%  

Financials

 WOCKHARDT   ABBOTT INDIA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ABBOTT INDIA
Mar-18
WOCKHARDT/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,0126,110 16.6%   
Low Rs5323,996 13.3%   
Sales per share (Unadj.) Rs355.91,552.2 22.9%  
Earnings per share (Unadj.) Rs-60.3188.8 -31.9%  
Cash flow per share (Unadj.) Rs-46.8196.4 -23.8%  
Dividends per share (Unadj.) Rs0.0155.00 0.0%  
Dividend yield (eoy) %01.1 0.1%  
Book value per share (Unadj.) Rs257.8796.6 32.4%  
Shares outstanding (eoy) m110.6321.25 520.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.3 66.6%   
Avg P/E ratio x-12.826.8 -47.8%  
P/CF ratio (eoy) x-16.525.7 -64.2%  
Price / Book Value ratio x3.06.3 47.2%  
Dividend payout %029.1 -0.1%   
Avg Mkt Cap Rs m85,379107,376 79.5%   
No. of employees `0006.33.3 188.3%   
Total wages/salary Rs m9,3713,937 238.0%   
Avg. sales/employee Rs Th6,295.09,929.3 63.4%   
Avg. wages/employee Rs Th1,498.31,185.1 126.4%   
Avg. net profit/employee Rs Th-1,066.31,207.7 -88.3%   
INCOME DATA
Net Sales Rs m39,36932,985 119.4%  
Other income Rs m1,2021,170 102.8%   
Total revenues Rs m40,57134,155 118.8%   
Gross profit Rs m185,245 0.3%  
Depreciation Rs m1,495162 923.6%   
Interest Rs m2,55538 6,688.2%   
Profit before tax Rs m-2,8306,215 -45.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2572,203 11.7%   
Profit after tax Rs m-6,6694,012 -166.2%  
Gross profit margin %015.9 0.3%  
Effective tax rate %-9.135.4 -25.6%   
Net profit margin %-16.912.2 -139.3%  
BALANCE SHEET DATA
Current assets Rs m33,79622,655 149.2%   
Current liabilities Rs m26,9176,681 402.9%   
Net working cap to sales %17.548.4 36.1%  
Current ratio x1.33.4 37.0%  
Inventory Days Days7965 122.5%  
Debtors Days Days8929 306.1%  
Net fixed assets Rs m39,664835 4,747.5%   
Share capital Rs m553213 260.3%   
"Free" reserves Rs m27,96816,715 167.3%   
Net worth Rs m28,52216,928 168.5%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62024,162 337.8%  
Interest coverage x-0.1163.7 -0.1%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.51.4 35.3%   
Return on assets %-5.016.8 -30.1%  
Return on equity %-23.423.7 -98.6%  
Return on capital %-7.736.9 -20.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,807369 2,661.1%   
Fx outflow Rs m1,7893,807 47.0%   
Net fx Rs m8,019-3,438 -233.2%   
CASH FLOW
From Operations Rs m6841,527 44.8%  
From Investments Rs m6,302-2,148 -293.4%  
From Financial Activity Rs m-7,695-1,024 751.2%  
Net Cashflow Rs m-664-1,646 40.4%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.3 7.9 29.1%  
FIIs % 7.7 0.1 7,700.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 17.1 90.1%  
Shareholders   67,757 18,270 370.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Strong Note; Sensex Ends 489 Points Higher(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

WOCKHARDT Plunges by 7%; BSE HEALTHCARE Index Down 0.4% (Market Updates)

Jun 20, 2019 | Updated on Jun 20, 2019

WOCKHARDT share price has plunged by 7% and its current market price is Rs 340. The BSE HEALTHCARE is down by 0.4%. The top gainers in the BSE HEALTHCARE Index are ERIS LIFESCIENCES LIMITED (up 2.6%) and APOLLO HOSPITALS (up 2.1%). The top losers is WOCKHARDT (down 6.9%)..

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jun 20, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - TORRENT PHARMA COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS